Louise Hecker
Works at
10 May 2024, reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
R41, Repurposing of FDA-approved Nrf2 Activators as a Novel Inhaled Therapy for Pulmonary Fibrosis, R41HL174346, 2024–2027, 10 May 2024, reporter.nih.gov